Abstract
The lower gastrointestinal tract is a major mucosal site of HIV entry and initial infection. Thus, the induction of strong cellular immune responses at this mucosal site will be an important feature of an effective HIV vaccine. We have used a novel prime-boost vaccination approach to induce immune responses at mucosal sites. Orally delivered recombinant Clostridium perfringens expressing HIV-1 gag (Cp-Gag) was evaluated for induction of HIV-1 Gag specific T cell responses in a prime-boost model with intranasal inoculation of HIV-1 virus like particles (VLP). HIV-1 specific cellular immune responses in both the effector (Lamina propria) and inductive sites (Peyers patches) of the gastrointestinal (GI) tract were significantly higher in mice immunized using Cp-Gag and VLPs in a prime-boost approach compared to mice immunized with either Cp-Gag or VLPs alone. Such cellular immune response was found to be mediated by both CD8+ and CD4+ T cells. Such a strong mucosal immune response could be very useful in developing a mucosal vaccine against HIV-1.
Keywords: HIV, mucosal vaccine, Clostridium perfringens, virus like particles, mucosal immunity, gastrointestinal tract, immune responses, Adjuvants, Immunization, Sample Collection
Current HIV Research
Title: Induction of Strong Anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV Gag and Virus Like Particles
Volume: 9 Issue: 8
Author(s): Poonam Pegu, Ruth Helmus, Phalguni Gupta, Patrick Tarwater, Lori Caruso, Chengli Shen, Ted Ross and Yue Chen
Affiliation:
Keywords: HIV, mucosal vaccine, Clostridium perfringens, virus like particles, mucosal immunity, gastrointestinal tract, immune responses, Adjuvants, Immunization, Sample Collection
Abstract: The lower gastrointestinal tract is a major mucosal site of HIV entry and initial infection. Thus, the induction of strong cellular immune responses at this mucosal site will be an important feature of an effective HIV vaccine. We have used a novel prime-boost vaccination approach to induce immune responses at mucosal sites. Orally delivered recombinant Clostridium perfringens expressing HIV-1 gag (Cp-Gag) was evaluated for induction of HIV-1 Gag specific T cell responses in a prime-boost model with intranasal inoculation of HIV-1 virus like particles (VLP). HIV-1 specific cellular immune responses in both the effector (Lamina propria) and inductive sites (Peyers patches) of the gastrointestinal (GI) tract were significantly higher in mice immunized using Cp-Gag and VLPs in a prime-boost approach compared to mice immunized with either Cp-Gag or VLPs alone. Such cellular immune response was found to be mediated by both CD8+ and CD4+ T cells. Such a strong mucosal immune response could be very useful in developing a mucosal vaccine against HIV-1.
Export Options
About this article
Cite this article as:
Pegu Poonam, Helmus Ruth, Gupta Phalguni, Tarwater Patrick, Caruso Lori, Shen Chengli, Ross Ted and Chen Yue, Induction of Strong Anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV Gag and Virus Like Particles, Current HIV Research 2011; 9 (8) . https://dx.doi.org/10.2174/157016211798998808
DOI https://dx.doi.org/10.2174/157016211798998808 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases
Current Pharmaceutical Design The Pathophysiological Basis of Renal Nerve Ablation for the Treatment of Hypertension
Current Vascular Pharmacology R848, a Toll-Like Receptors 7 and 8 Agonist, a Potential Therapy for Allergic Rhinitis Patients
Inflammation & Allergy - Drug Targets (Discontinued) Recent Advances in the Management of Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Intramolecular Immunological Signal Hypothesis Revived - Structural Background of Signalling Revealed by Using Congo Red as a Specific Tool
Mini-Reviews in Medicinal Chemistry Protective Effect of Urate Oxidase on Uric Acid Induced-Monocyte Apoptosis
Current Drug Discovery Technologies The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Regulatory T Cells in Atopic Dermatitis
Recent Patents on Inflammation & Allergy Drug Discovery Involvement of Dendritic Cells in Allograft Rejection New implications of Dendritic Cell-Endothelial Cell Interactions
Mini-Reviews in Medicinal Chemistry Patents in Therapeutic Recombinant Protein Production Using Mammalian Cells
Recent Patents on Biotechnology Hepatic Diseases Related to Triglyceride Metabolism
Mini-Reviews in Medicinal Chemistry Anti-Inflammatory Effects of Plasma Circulating Exosomes Obtained from Normal-Weight and Obese Subjects on Hepatocytes
Endocrine, Metabolic & Immune Disorders - Drug Targets The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry Zinc-Aceclofenac Complex: Synthesis, Hydrolysis Study and Antiinflammatory Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury
Current Neuropharmacology Convection-Enhanced Delivery: Neurosurgical Issues
Current Drug Targets Clopidogrel Hypersensitivity: Overview of the Problem
Current Vascular Pharmacology The Role of Chymase in Vascular Remodeling and Tissue Fibrosis
Current Hypertension Reviews The Role of STAT 3 in Tissue Fibrosis
Current Chemical Biology Intratubular Renin-Angiotensin System in Hypertension
Current Hypertension Reviews